Earl Bergey - Nanobiotix CoFounder
| NANO Stock | EUR 5.45 0.04 0.73% |
Insider
Earl Bergey is CoFounder of Nanobiotix SA
| Age | 68 |
| Phone | 33 1 40 26 04 70 |
| Web | https://www.nanobiotix.com |
Nanobiotix Management Efficiency
The company has return on total asset (ROA) of (0.2916) % which means that it has lost $0.2916 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.9869) %, meaning that it generated substantial loss on money invested by shareholders. Nanobiotix's management efficiency ratios could be used to measure how well Nanobiotix manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Pierre Boulud | Biomerieux SA | 52 | |
| Peter Dalsberg | Socit BIC SA | N/A | |
| Gregory Sanson | Bonduelle SCA | N/A | |
| Gianfranco DAmico | Bonduelle SCA | N/A | |
| Yasha Mitrotti | Biomerieux SA | N/A | |
| Alexandre Merieux | Biomerieux SA | 49 | |
| Michel Torris | Bonduelle SCA | N/A | |
| Thomas Brette | Socit BIC SA | N/A | |
| Valerie Leylde | Biomerieux SA | N/A | |
| Benoit Bonduelle | Bonduelle SCA | N/A | |
| Petra Zalabak | Guerbet S A | N/A | |
| Guillaume Debrosse | Bonduelle SCA | N/A | |
| Sophie PalliezCapian | Socit BIC SA | N/A | |
| Chad Spooner | Socit BIC SA | 51 | |
| Mallory Martino | Socit BIC SA | N/A | |
| Charlotte Bamiere | Guerbet S A | N/A | |
| Mark Miller | Biomerieux SA | N/A | |
| Valrie Brissart | Guerbet S A | N/A | |
| Gonzalve Bich | Socit BIC SA | 44 | |
| Marine Henin | Bonduelle SCA | N/A | |
| Pierre Charbonnier | Biomerieux SA | N/A | |
Management Performance
| Return On Equity | -1.99 | |||
| Return On Asset | -0.29 |
Nanobiotix SA Leadership Team
Elected by the shareholders, the Nanobiotix's board of directors comprises two types of representatives: Nanobiotix inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Nanobiotix. The board's role is to monitor Nanobiotix's management team and ensure that shareholders' interests are well served. Nanobiotix's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Nanobiotix's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sarah Gaubert, Head Department | ||
| Elsa Borghi, Head Discovery | ||
| Brandon Owens, VP Communication | ||
| Earl Bergey, CoFounder | ||
| Kathryn McNeil, VP Relations | ||
| AnneJuliette MA, Chief Board | ||
| Bart Rhijn, CFO Board | ||
| Pr Prasad, CoFounder Board | ||
| Alain Dostie, Chief Officer | ||
| Laurent Levy, Pres CoFounder |
Nanobiotix Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Nanobiotix a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.99 | |||
| Return On Asset | -0.29 | |||
| Operating Margin | (17.96) % | |||
| Current Valuation | 111.08 M | |||
| Shares Outstanding | 34.88 M | |||
| Shares Owned By Insiders | 3.78 % | |||
| Shares Owned By Institutions | 25.56 % | |||
| Price To Earning | (12.17) X | |||
| Price To Book | 71.98 X | |||
| Price To Sales | 48.04 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nanobiotix SA. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Nanobiotix Stock refer to our How to Trade Nanobiotix Stock guide.You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Complementary Tools for Nanobiotix Stock analysis
When running Nanobiotix's price analysis, check to measure Nanobiotix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nanobiotix is operating at the current time. Most of Nanobiotix's value examination focuses on studying past and present price action to predict the probability of Nanobiotix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nanobiotix's price. Additionally, you may evaluate how the addition of Nanobiotix to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |